Statement from Senate Republican Leaders on Workplace Harassment
Senate President Pro Tempore Kim Ward (R-39), Senate Majority Leader Joe Pittman (R-41), Senate Majority Appropriations Chair Scott Martin (R-13), Senate Majority Whip Ryan Aument (R-36), Senate Majority Caucus Chair Kristin Phillips-Hill (R-28), Senate Majority Caucus Secretary Camera Bartolotta (R-46), Senate Majority Policy Chair Dan Laughlin (R-49) and Senate Majority Caucus Administrator Lisa Baker (R-20), today issued the following statement on workplace harassment: [Read More]
Historic Breast Cancer Screening Bill Unanimously Passes PA Senate
The Pennsylvania Senate today unanimously passed Senate Bill 8, a first-of-its-kind in the nation comprehensive breast cancer screening bill sponsored by Senate President Pro Tempore Kim Ward (R-39), Senator Devlin Robinson (R-37) and Senator Tracy Pennycuick (R-24). [Read More]
Senate Republicans to Respond to Shapiro’s Budget Address
Senate Republicans will respond to Gov. Josh Shapiro’s spending proposal on Tuesday, March 7, shortly following the delivery of the budget address, on the balcony outside the lieutenant governor’s office on the second floor of the Main Capitol Rotunda. [Read More]
Senate Republican Caucus Announces Principles and Priorities for 2023-24 Session
Senate Republican leaders laid out an ambitious set of principles and priorities today to strengthen Pennsylvania by protecting jobs, empowering families and defending freedoms. [Read More]
Senate Republicans to Announce Priorities for 2023-24 Legislative Session
Senate Republicans will announce their principles and priorities for the 2023-24 legislative session on Wednesday, March 1, at 11 a.m. in the Capitol Media Center, Capitol Complex, Harrisburg. [Read More]
Senate Committee Votes to Eliminate Costs for Genetic Testing and Breast Cancer Screenings
Chairman John DiSanto (R-15) convened the Senate Banking and Insurance Committee for its first voting meeting of the 2023-24 legislative session today to unanimously approve Senate Bill 8, which eliminates all out-of-pocket costs for genetic testing of hereditary cancer syndromes and supplemental breast screenings for women with a high lifetime-risk of developing breast cancer. [Read More]